Trial Information
Current as of September 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to collect detailed images of the eye using a special scanning method called Optical Coherence Tomography (OCT). These images help doctors see the different layers of the eye, which is important for understanding both healthy eyes and those affected by conditions like retinal disease, glaucoma, or corneal diseases. The goal is to gather information that could improve eye care and treatments in the future.
Anyone aged 18 and older, whether they have an eye condition or not, may be able to take part in this study. Participants will have their eyes scanned using the OCT machine, which is a quick and painless test that uses light to create clear pictures of the inside of the eye. This study is currently looking for volunteers, and taking part could help researchers learn more about eye health and disease.
Gender
ALL
Eligibility criteria
About Optos, Plc
Optos, plc is a leading medical technology company specializing in the development and manufacturing of advanced retinal imaging devices. With a commitment to enhancing the diagnosis and management of eye diseases, Optos employs innovative technologies to provide high-resolution, wide-field imaging solutions that improve clinical outcomes for patients. The company collaborates closely with healthcare professionals and researchers to advance ophthalmic care and support clinical trials that aim to expand the understanding of retinal conditions. Through its dedication to innovation and quality, Optos is at the forefront of transforming eye care and contributing to the field of ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported